You are here: Industry Insights > Clinical Trial

News List

Virtual clinical trials would have a tremendous advantage in expanding the reach of clinical trials expresspharma
January 04, 2021
Suneela Thatte, VP and Head - R&D Solutions India, IQVIA speaks on the challenges faced by CROs due to the pandemic, the subsequent learnings in clinical research/trials, emerging trends in this arena and more, in an interaction with Viveka Roychowdhury.
COVAXIN clinical trials recruit 23,000 subjects expresspharma
January 04, 2021
COVAXIN has been evaluated in approximately 1000 subjects in Phase I and Phase II clinical trials, with promising safety and immunogenicity results.
QYNAPSE Joins Decentralized Trials & Research Alliance (DTRA) To Democratize And Accelerate Clinical Trials prnewswire
December 31, 2020
QYNAPSE Inc. joins a historic alliance of fifty life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research.
SEC asks Bharat Serums to revise phase I/II trial protocols for equine antiserum to treat COVID-19 expresspharma
December 29, 2020
The SEC has recommended grant of permission to conduct the clinical trial provided the company submits the revised clinical trial protocol to CDSCO.
Arctic Vision obtains the first IND approval for the treatment of UME in China, Suprachoroidal space (SCS) injection potentially brings more benefits to patients prnasia
December 28, 2020
Arctic Vision, a China-based clinical-stage ophthalmology company with a leading portfolio of breakthrough technologies, announced on December 24th the clearance of the Investigational New Drug (IND) for Phase III trial of ARVN001 (triamcinolone ...
Zydus seeks approval for Phase III clinical trials of ZyCoV-D, submits Phase I/II clinical trial data expresspharma
December 28, 2020
ZyCoV-D was found to be safe, well tolerated and immunogenic in the Phase I/II clinical trials, informs company.
INOVIO Announces Publication of Phase 1 Data from its COVID-19 DNA Vaccine Candidate, INO-4800 in The Lancet's EClinicalMedicine prnasia
December 25, 2020
INOVIO announced the publication of peer-reviewed Phase 1 clinical data from the first cohort of 40 participants for its COVID-19 DNA vaccine candidate, INO-4800, in EClinicalMedicine, an open access clinical journal published by The Lancet.
Phase I clinical trial outcome shows Covaxin generates antibody, T-cell memory response expresspharma
December 24, 2020
Bharat Biotech’s COVID-19 vaccine Covaxin has shown positive long term antibody and T cell memory response in Phase I clinical trial.
49 per cent of clinical trial disruption due to slow enrollment- GlobalData expresspharma
December 22, 2020
The fastest rate of trial disruption was between early April and mid-May, and the number of trials disrupted by COVID-19 peaked in the first week of June
ImmuneMed's hzVSF-v13, COVID-19 clinical trials accelerate development of the treatment prnasia
December 21, 2020
The broad spectrum antiviral therapeutic, 'hzVSF-v13(humanized Virus Suppressing Factor)' being developed by ImmuneMed, is on track to progress as a treatment for the COVID-19 pneumonia patients.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page